Future research and methodological approaches

被引:4
作者
Pater, J. [1 ]
Rochon, J. [2 ]
Parmar, M. [3 ]
Selby, P. [4 ,5 ]
机构
[1] Queens Univ, Kingston, ON, Canada
[2] Heidelberg Univ, Inst Med Biometry & Informat, D-6900 Heidelberg, Germany
[3] MRC Clin Trials Unit, Canc Div, London, England
[4] Natl Inst Hlth Res Clin Res Network, Leeds, W Yorkshire, England
[5] Leeds Inst Mol Med, Leeds, W Yorkshire, England
关键词
CLINICAL-TRIALS; CANCER; CARE; DESIGN; PARTICIPATION; SURVIVAL; OUTCOMES;
D O I
10.1093/annonc/mdr428
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This supplement has explored the evidence for benefits from the participation of healthcare institutions and their patients in clinical research. The questions have been clarified. There is some encouragement that research active healthcare institutions may deliver improved outcomes compared to less research-active or research-inactive institutions but there is a pressing need for further research. In this chapter we explore the methodological challenges to evaluating the impact of the process of clinical research on hospitals and other healthcare organizations. The postulated mechanisms by which benefits may be accrued are important drivers of the types of research needed and these are emphasized. Study designs are explored including formal randomized trials, the stepped wedge randomized design, approaches to the design and analysis of observational studies particularly to examine whether a temporal or spatial relationship exists between changes in research activity and patients' outcomes. It is acknowledged that in most future studies the data available will be cross-sectional and observational, and such studies are susceptible to many types of bias. The importance of identifying and addressing such biases in multivariate analysis is discussed and examples of successful studies are given.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 29 条
[1]  
[Anonymous], 1987, CANCER RES, V47, P5782
[2]   Pharmaceutical policies: effects of cap and co-payment on rational drug use [J].
Austvoll-Dahlgren, A. ;
Aaserud, M. ;
Vist, G. ;
Ramsay, C. ;
Oxman, A. D. ;
Sturm, H. ;
Koesters, J. P. ;
Vernby, A. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01)
[3]   THE PAIRED AVAILABILITY DESIGN - A PROPOSAL FOR EVALUATING EPIDURAL ANALGESIA DURING LABOR [J].
BAKER, SG ;
LINDEMAN, KS .
STATISTICS IN MEDICINE, 1994, 13 (21) :2269-2278
[4]   Comparing cancer mortality rates before-and-after a change in availability of screening in different regions: Extension of the paired availability design [J].
Baker S.G. ;
Kramer B.S. ;
Prorok P.C. .
BMC Medical Research Methodology, 4 (1) :1-24
[5]   THE MODERATOR MEDIATOR VARIABLE DISTINCTION IN SOCIAL PSYCHOLOGICAL-RESEARCH - CONCEPTUAL, STRATEGIC, AND STATISTICAL CONSIDERATIONS [J].
BARON, RM ;
KENNY, DA .
JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY, 1986, 51 (06) :1173-1182
[6]   Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect" [J].
Braunholtz, DA ;
Edwards, SJL ;
Lilford, RJ .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2001, 54 (03) :217-224
[7]  
Brown CA., 2006, BMC MED RES METHODOL, V6, P54, DOI DOI 10.1186/1471-2288-6-54
[8]   Relevance of clinical trial results in myocardial infarction to medical practice: comparison of four year outcome in participants of a thrombolytic trial, patients receiving routine thrombolysis, and those deemed ineligible for thrombolysis [J].
Brown, N ;
Melville, M ;
Gray, D ;
Young, T ;
Skene, AM ;
Wilcox, RG ;
Hampton, JR .
HEART, 1999, 81 (06) :598-602
[9]   Research-intensive cancer care in the NHS in the UK [J].
Cameron, D. ;
Stead, M. ;
Lester, N. ;
Parmar, M. ;
Haward, R. ;
Maughan, T. ;
Wilson, R. ;
Spaull, A. ;
Campbell, H. ;
Hamilton, R. ;
Stewart, D. ;
O'Toole, L. ;
Kerr, D. ;
Potts, V. ;
Moser, R. ;
Cooper, M. ;
Poole, K. ;
Darbyshire, J. ;
Kaplan, R. ;
Seymour, M. ;
Selby, P. .
ANNALS OF ONCOLOGY, 2011, 22 :29-35
[10]   Effects on patients of their healthcare practitioner's or institution's participation in clinical trials: a systematic review [J].
Clarke, Mike ;
Loudon, Kirsty .
TRIALS, 2011, 12